Search results
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong Financials Guiding The...
Simply Wall St. via Yahoo Finance· 15 hours agoMost readers would already know that Catalyst Pharmaceuticals' (NASDAQ:CPRX) stock increased by 4.1%...
Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders have endured a 76% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 2 days agoAs every investor would know, not every swing hits the sweet spot. But you want to avoid the really...
It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put...
Simply Wall St. via Yahoo Finance· 19 hours agoPharmaceuticals' EPS declined by 9.8% over the past three years while total shareholder loss over...
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Brokerages
ETF DAILY NEWS· 1 day agoFusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) has been assigned a consensus rating of...
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Buy by Jefferies Financial Group
ETF DAILY NEWS· 23 hours agoCollegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating ...
Insider Sale: CEO Brian Goff Sells Shares of Agios Pharmaceuticals Inc (AGIO)
GuruFocus.com via Yahoo Finance· 7 hours agoOn June 5, 2024, Brian Goff, Chief Executive Officer of Agios Pharmaceuticals Inc (NASDAQ:AGIO),...
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) the Leading Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Ori Gutwerg Sells 2,985 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock
ETF DAILY NEWS· 21 hours agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) SVP Ori Gutwerg sold 2,985 shares of the stock in a transaction dated Wednesday, June 5th. The ...
With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case
Simply Wall St. via Yahoo Finance· 16 hours agoDespite being in the age of tech-stock blue-sky investing, many investors still adopt a more...
Collegium Pharmaceutical stock upgraded from Hold to Buy By Investing.com
Investing.com· 18 hours agoOn Friday, Collegium Pharmaceutical Inc. (NASDAQ:COLL) received an upgrade from Jefferies from Hold...